Non-segmental Vitiligo (DBCOND0053135)

Identifiers

Synonyms

Non Segmental Vitiligo / NonSegmental Vitiligo

Associated Data

Indicated Drugs and Targets

Drug	Description	Targets
Ruxolitinib	A kinase inhibitor used to treat various types of myelofibrosis, polycythemia vera in patients who have not responded to or cannot tolerate hydroxyurea, and to treat graft-versus-host disease in cases that are refractory to steroid treatment.	Tyrosine-protein kinase JAK1target Tyrosine-protein kinase JAK2target Cytochrome P450 3A4enzyme Cytochrome P450 2C9enzyme Albumincarrier Tyrosine-protein kinase JAK3target Non-receptor tyrosine-protein kinase TYK2target Urokinase plasminogen activator surface receptortarget

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT06619184	Transplantation of Autologous Non-Cultured Extracted Hair Follicle Outer Root Sheath Cell Suspension and Mini Punch Graft for Stable Non-Segmental Vitiligo Lesions	No drug interventions	treatment	Not Available	completed
NCT06113445	A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V1)	Povorcitinib	treatment	3	recruiting
NCT06113471	A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V2)	Povorcitinib	treatment	3	recruiting
NCT06548360	A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo	Ruxolitinib	treatment	3	not_yet_recruiting
NCT04818346	A Study to Evaluate the Efficacy and Safety of INCB054707 in Participants With Vitiligo	Povorcitinib	treatment	2	completed
NCT06113328	A Clinical Study of MK-6194 for the Treatment of Vitiligo (MK-6194-007)	No drug interventions	treatment	2	active_not_recruiting
NCT04927975	Study to Evaluate Adverse Events and Change in Disease Activity With Oral Tablets of Upadacitinib in Adult Participants With Non-Segmental Vitiligo	Upadacitinib	treatment	2	completed
NCT06493578	A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of VYN201 Gel in Subjects with Non-segmental Vitiligo.	No drug interventions	treatment	2	recruiting
NCT03247400	The Evaluation of Vitiligous Lesions Repigmentation After the Administration of Atorvastatin Calcium Salt and Simvastatin-acid Sodium Salt in Patients With Active Vitiligo	Atorvastatin Simvastatin	treatment	1 / 2	completed
NCT06511739	A Study to Evaluate the Efficacy and Safety of SYHX1901 Tablet in Non-segmental Vitiligo Patients	No drug interventions	treatment	2	recruiting
NCT04052425	Topical Ruxolitinib Evaluation in Vitiligo Study 1 (TRuE-V1)	Ruxolitinib	treatment	3	completed
NCT01377077	Punchgrafting Techniques for Vitiligo	No drug interventions	treatment	4	unknown_status
NCT05990309	ASSESSMENT OF TRISTETRAPROLIN EXPRESSION IN LESIONAL SKIN OF PATIENTS WITH NON SEGMENTAL VITILIGO	No drug interventions	diagnostic	Not Available	not_yet_recruiting
NCT03022019	ReNovaCell in Non-segmental Vitiligo	No drug interventions	treatment	Not Available	terminated
NCT04811326	Latanoprost Plus NB-UVB Versus Each Alone in Non-segmental Vitiligo: Clinical and Laboratory Evaluation	Latanoprost	treatment	4	active_not_recruiting
NCT04057573	Topical Ruxolitinib Evaluation in Vitiligo Study 2 (TRuE-V2)	Ruxolitinib	treatment	3	completed
NCT04942860	The Evaluation of Vitiligous Lesions Repigmentation After Topical Administration of Methotrexate in Patients With Active Vitiligo	Methotrexate	treatment	3	completed
NCT04487860	Efficacy and Safety of AS012 in Subjects With Non-segmental Vitiligo	No drug interventions	treatment	2	completed